Prolonged ruxolitinib cream treatment for vitiligo among patients with no or limited response in the first 6 months - PubMed
4 days ago
- #ruxolitinib
- #vitiligo
- #clinical-trial
- Prolonged ruxolitinib cream treatment for vitiligo patients with no or limited response in the first 6 months.
- References include expert recommendations for vitiligo diagnosis and management, phase 3 trials of ruxolitinib cream, and insights into novel treatments.
- Keywords highlight Janus kinase inhibitors, clinical trials, and therapeutic studies related to vitiligo.